SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015753
Filing Date
2022-08-09
Accepted
2022-08-09 07:31:08
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-20220630.htm   iXBRL 10-Q 1881680
2 EX-10.1 grtx-ex10_1.htm EX-10.1 63697
3 EX-31.1 grtx-ex31_1.htm EX-31.1 18655
4 EX-31.2 grtx-ex31_2.htm EX-31.2 21593
5 EX-32.1 grtx-ex32_1.htm EX-32.1 10503
6 EX-32.2 grtx-ex32_2.htm EX-32.2 9244
  Complete submission text file 0000950170-22-015753.txt   5939520

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grtx-20220630_cal.xml EX-101.CAL 37644
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grtx-20220630_def.xml EX-101.DEF 95313
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grtx-20220630_pre.xml EX-101.PRE 222769
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grtx-20220630_lab.xml EX-101.LAB 334347
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grtx-20220630.xsd EX-101.SCH 38490
53 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20220630_htm.xml XML 904845
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 221146413
SIC: 2834 Pharmaceutical Preparations